Sanjay Malhotra,Governor,Reserve Bank of India Malhotra, who faces...
Category:
Indian News
Latest
India has 1,065 dams 50-100 years old, 224 are hundred plus: Govt
According to the National Register of Large Dams (NRLD-2023...
LIC unclaimed maturity amounts reach Rs881 cr in FY24
As many as 3,72,282 policyholders did not claim maturity benefits...
Facebook teams up with Indian firm to help provide loans to small businesses
The social media giant is joining hands with Indifi to help provide loans ranging from 500,000 rupees to 5,000,000 rupees ($6,719-$67,191) at annual interest rates of up to 20%, Ajit Mohan, Facebook India’s managing director, told a virtual news conference.
India to add 100 more earthquake observatories by 2026: Jitendra Singh
He impressed upon India’s commitment to supporting various projects of earth system science to quantify the seismic hazard for better land use and urban planning and creating disaster-resilient infrastructures for reducing risks and ultimately paving the way to sustainable development.
July non-life insurance premiums shrug off pandemic cloud: Care Ratings
Non-life insurance premium reached Rs 20,171 crore compared to Rs 16,885 crore in July 2020. The growth was driven by health and fire segments with motor segment also turning in positive numbers.
Post LIC IPO, 60 pc of insurance biz to be with listed entities: FinMin official
The insurance sector, over the two decades since the introduction of competition and regulation, has matured with 69 insurers today as against only eight in 2000. ‘A majority of these have crossed their initial breakeven phase. Once the proposed listing of LIC happens, about 60 per cent of the insurance industry business would be with listed entities. The sector as a whole has been growing at a pace significantly higher than that of the overall economy, additional secretary in the finance ministry Amit Agarwal said
J&J seeks nod for COVID-19 vaccine trial in Indian adolescents
Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in an emailed statement.
The U.S. pharma giant had received emergency use approval for its single-dose vaccine in India earlier this month, making it the fifth authorised vaccine in the country. read more
FDI proposal for bank-promoted insurance firm to be vetted by RBI, Irdai: Govt notification
”Applications for foreign direct investment in private banks having joint venture or subsidiary in insurance sector may be addressed to the Reserve Bank for consideration in consultation with the Insurance Regulatory and Development Authority of India (IRDAI), in order to ensure that the limit of foreign investment applicable for the insurance sector as specified in serial number F. 8.1 and F. 8.2 is not breached,” the notification said.
India approves Zydus Cadila’s ZyCoV-D vaccine for emergency use for adults and children above 12 yrs
Chairperson of the Zydus Group, Pankaj R Patel said, “We are extremely happy that our efforts to put out a safe, well-tolerated and efficacious vaccine to fight COVID-19 has become a reality with ZyCoV-D. To create the world’s first DNA vaccine at such a crucial juncture and despite all the challenges, is a tribute to the Indian research scientists and their spirit of innovation. I’d like to thank the Department of Biotechnology under the Government of India for their support in this mission of Atma Nirbhar Bharat and Indian Vaccine Mission COVID Suraksha.”
RBI Guv pitches for continued policy support to revive growth, monitoring inflation
”The need of the hour is twofold: first, continue the monetary policy support to the economy; and second, remain watchful of any durable inflationary pressures and sustained price momentum in key components so as to bring back the CPI inflation to 4 per cent over a period of time in a non-disruptive manner,” he said.
EPFO adds 1.283 million members in June amid Covid-19
Of the total 12.83 lakh net subscribers added in June, around 8.11 lakh have come under the social security coverage of Employees’ Provident Fund scheme for the first time.
Ayushman Bharat: Over 0.7 mn Covid treatments authorised from Apr’20-Jul’21
“Under the Ayushman Bharat health insurance scheme, over 20 lakh tests and 7.25 lakh COVID-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021.The insurance scheme allows the beneficiaries to avail free testing and treatment across all empanelled — both public and private — hospitals,” an official said.